Bjøŕn Skogen

3.2k total citations
80 papers, 2.3k citations indexed

About

Bjøŕn Skogen is a scholar working on Hematology, Genetics and Immunology and Allergy. According to data from OpenAlex, Bjøŕn Skogen has authored 80 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 18 papers in Genetics and 15 papers in Immunology and Allergy. Recurrent topics in Bjøŕn Skogen's work include Platelet Disorders and Treatments (54 papers), Blood groups and transfusion (48 papers) and Blood disorders and treatments (16 papers). Bjøŕn Skogen is often cited by papers focused on Platelet Disorders and Treatments (54 papers), Blood groups and transfusion (48 papers) and Blood disorders and treatments (16 papers). Bjøŕn Skogen collaborates with scholars based in Norway, Sweden and United States. Bjøŕn Skogen's co-authors include Anne Husebekk, Gunnar Husby, J. B. Natvig, Jens Kjeldsen‐Kragh, Mette Kjær Killie, Gudmund Marhaug, Per Westermark, Knut Sletten, Heidi Tiller and Terje E. Michaelsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Bjøŕn Skogen

77 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bjøŕn Skogen Norway 24 1.3k 793 596 278 256 80 2.3k
N Williams Australia 25 1.3k 1.0× 509 0.6× 204 0.3× 215 0.8× 734 2.9× 54 2.3k
F Takaku Japan 20 528 0.4× 639 0.8× 250 0.4× 161 0.6× 572 2.2× 59 1.9k
H Rochant France 26 978 0.8× 604 0.8× 192 0.3× 390 1.4× 336 1.3× 107 1.9k
TR Bradley Australia 11 903 0.7× 615 0.8× 254 0.4× 263 0.9× 807 3.2× 18 2.2k
W. J. Judd United States 22 899 0.7× 401 0.5× 268 0.4× 587 2.1× 250 1.0× 76 1.5k
P Bourdon United States 13 401 0.3× 533 0.7× 149 0.3× 43 0.2× 576 2.3× 14 1.6k
Yasuhiro Horii Japan 8 591 0.5× 558 0.7× 103 0.2× 76 0.3× 560 2.2× 14 1.6k
Gianfranco Mattia Italy 28 476 0.4× 1.4k 1.7× 131 0.2× 65 0.2× 440 1.7× 54 2.4k
Lacramioara Ivanciu United States 17 497 0.4× 456 0.6× 128 0.2× 64 0.2× 324 1.3× 31 1.3k
B. Gardner United Kingdom 22 547 0.4× 356 0.4× 152 0.3× 484 1.7× 315 1.2× 40 1.2k

Countries citing papers authored by Bjøŕn Skogen

Since Specialization
Citations

This map shows the geographic impact of Bjøŕn Skogen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjøŕn Skogen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjøŕn Skogen more than expected).

Fields of papers citing papers by Bjøŕn Skogen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjøŕn Skogen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjøŕn Skogen. The network helps show where Bjøŕn Skogen may publish in the future.

Co-authorship network of co-authors of Bjøŕn Skogen

This figure shows the co-authorship network connecting the top 25 collaborators of Bjøŕn Skogen. A scholar is included among the top collaborators of Bjøŕn Skogen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjøŕn Skogen. Bjøŕn Skogen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geisen, Christof, Carmen Walter, Jens Søndergaard Jensen, et al.. (2024). A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention. Thrombosis and Haemostasis. 125(4). 352–363.
2.
Geisen, Christof, Mette Kjær, Bjøŕn Skogen, et al.. (2023). An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study. Journal of Thrombosis and Haemostasis. 21(4). 838–849. 3 indexed citations
3.
Dahl, Jesper, Bjøŕn Skogen, Mette Kjær, et al.. (2020). A combined effect of anti‐HPA‐1a and anti‐HLA Class I in pregnancy?. Transfusion. 60(9). 2121–2129. 3 indexed citations
4.
Tiller, Heidi, Anne Husebekk, Maria Therese Ahlén, Tor B. Stuge, & Bjøŕn Skogen. (2017). Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities. International Journal of Women s Health. Volume 9. 223–234. 24 indexed citations
5.
Ahlén, Maria Therese, et al.. (2016). T cell responses to human platelet antigen–1a involve a unique form of indirect allorecognition. JCI Insight. 1(14). e86558–e86558. 10 indexed citations
6.
Kapur, Rick, Carolien A. M. Koeleman, Leendert Porcelijn, et al.. (2013). A PROMINENT LACK OF IGG1 FC-FUCOSYLATION OF PLATELET-ALLOANTIBODIES IN PREGNANCY. Vox Sanguinis. 105. 13–14. 2 indexed citations
7.
Kapur, Rick, Carolien A. M. Koeleman, Remco Visser, et al.. (2013). A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood. 123(4). 471–480. 165 indexed citations
8.
9.
Ahlén, Maria Therese, Anne Husebekk, Mette Kjær Killie, et al.. (2011). The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to MaternalABOGenotypes. SHILAP Revista de lepidopterología. 2012. 1–5. 13 indexed citations
10.
Skogen, Bjøŕn, Mette Kjær Killie, Jens Kjeldsen‐Kragh, et al.. (2010). Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Review of Hematology. 3(5). 559–566. 31 indexed citations
11.
Skogen, Bjøŕn, et al.. (2009). Neonatal Alloimmune Thrombocytopenia is Not What It was A Lesson Learned from a Large Prospective Screening and Intervention Program. Scandinavian Journal of Immunology. 70(6). 531–534. 16 indexed citations
12.
Bessos, Hagop, Mette Kjær Killie, Jerard Seghatchian, Bjøŕn Skogen, & S. J. Urbaniak. (2009). The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia – Where does it stand?. Transfusion and Apheresis Science. 40(2). 75–78. 13 indexed citations
13.
Husebekk, Anne, et al.. (2008). A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica. 93(6). 870–877. 106 indexed citations
14.
Killie, Mette Kjær, Anne Husebekk, Cécile Kaplan, Ellen Taaning, & Bjøŕn Skogen. (2006). Maternal human platelet antigen‐1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion. 47(1). 55–58. 34 indexed citations
15.
16.
Husebekk, Anne & Bjøŕn Skogen. (2001). Maternelle alloantistoffers betydning ved trombocytopeni hos nyfødte. Tidsskrift for Den Norske Laegeforening.
17.
Skogen, Bjøŕn, Daniel B. Bellissimo, Martin J. Hessner, et al.. (1994). Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele‐specific primers. Transfusion. 34(11). 955–960. 122 indexed citations
18.
Skogen, Bjøŕn, et al.. (1987). Intravenously injected anti-cardiac myosin monoclonal antibody specifically demarcates cardiac rejection.. Transplantation Proceedings. 19. 1053–1055. 3 indexed citations
19.
Rekvig, Ole Petter, et al.. (1987). Human Antinuclear Autoantibodies Crossreacting with the Plasma Membrane and the N-Terminal Region of Histone H2B. Immunological Investigations. 16(7). 535–547. 19 indexed citations
20.
Skogen, Bjøŕn & J. B. Natvig. (1981). Degradation of Amyloid Proteins by Different Serine Proteases. Scandinavian Journal of Immunology. 14(4). 389–396. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N Williams Breakdown of academic impact, for papers by F Takaku Breakdown of academic impact, for papers by H Rochant Breakdown of academic impact, for papers by TR Bradley Breakdown of academic impact, for papers by W. J. Judd Breakdown of academic impact, for papers by P Bourdon Breakdown of academic impact, for papers by Yasuhiro Horii Breakdown of academic impact, for papers by Gianfranco Mattia Breakdown of academic impact, for papers by Lacramioara Ivanciu Breakdown of academic impact, for papers by B. Gardner
Rankless by CCL
2026